Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

SELL
$0.0 - $0.36 $0 - $800
-2,224 Reduced 95.7%
100 $0
Q1 2023

Apr 27, 2023

BUY
$0.12 - $0.3 $258 - $645
2,150 Added 1235.63%
2,324 $0
Q4 2022

Feb 02, 2023

BUY
$0.15 - $0.63 $26 - $109
174 New
174 $0
Q3 2021

Oct 28, 2021

SELL
$12.22 - $21.28 $2,444 - $4,256
-200 Reduced 5.93%
3,174 $43,000
Q2 2021

Aug 12, 2021

BUY
$9.0 - $15.94 $30,366 - $53,781
3,374 New
3,374 $46,000

Others Institutions Holding PLXP

About PLx Pharma Inc.


  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.